MCKEW JOHN C. (Chief Scientific Officer) sold 11.4% of their position (2.21K shares) of LUMOS PHARMA, INC. on the open market
Open‑market sale worth $6.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2024ACC: 0001126234-24-000036
Officer· Chief Scientific Officer
Since Mar 2020
+14.75K
Net shares
Net buyer
$9.1K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
18K acquired · 3.25K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2K
Price / share
$2.84
Trade value
$5.68K
% of position
10.9%
4/1/2024
18.40K→20.40K
Common Stock
Direct
Shares
−1.04K
Price / share
$2.84
Trade value
$2.94K
% of position
5.1%
4/1/2024
20.40K→19.37K
Common Stock
Direct
Shares
−2.21K
Price / share
$2.77
Trade value
$6.14K
% of position
11.4%
4/3/2024
19.37K→17.15K
Total
Net shares
−1.25K
Net value
-$3.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2024 | A · Award | +2K | $2.84 | $5.68K | 10.9% | 18.40K | 20.40K |
| Common Stock Direct | 4/1/2024 | F · Tax Withholding | −1.04K | $2.84 | $2.94K | 5.1% | 20.40K | 19.37K |
| Common Stock Direct | 4/3/2024 | S · Sale | −2.21K | $2.77 | $6.14K | 11.4% | 19.37K | 17.15K |
| Total | −1.25K | -$3.41K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
16K shares
Shares
+16K
Strike price
2.84
Held after
16K
Exercisable
—
4/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16K shares | 4/1/2024 | A · Award | +16K | 2.84 | — | 16K |